A new study reveals significant associations between changes in sarcopenia status and cardiovascular disease risk, shedding light on the clinical characteristics and comorbidity prevalence in different groups.
In a study of patients with AF, >5 daily cups of coffee correlated with cognitive performance akin to being 6.7 years younger, alongside reductions in IL-6 levels, highlighting potential anti-inflammatory benefits.
Case-control study evaluates the association between cardiovascular disease and breast cancer stage at diagnosis, revealing potential links in specific subtypes.
In older adults at risk for dementia, a 24-week Mediterranean diet intervention led to sustained cognitive benefits and improved diet adherence for up to 12 months.
The FDA has approved the first generic GLP-1 injection for type 2 diabetes management, maintaining the safety profile and emphasizing clinical monitoring requirements for adverse effects.
A study revealed that physically active septuagenarians with obesity showed "younger" brain ages than their sedentary counterparts, suggesting exercise may help preserve brain structure regardless of body mass index.
A recent report in JAMA Ophthalmology reveals that Jardiance, an oral diabetes drug, may help prevent worsening of diabetic eye disease in patients with type 2 diabetes, offering valuable insights for clinical management.
A study evaluating systematic reviews used to develop dietary guidelines for Americans revealed 'critically low' quality and significant methodological weaknesses, raising concerns about reliability and reproducibility.